Shares of Catalyst Pharmaceuticals slid 7.71% to $3.95 at 14:13 EST on Tuesday, following last session’s downward trend. NASDAQ Composite is sliding 1.65% to $13,309.70, following last session’s downward trend, This seems, up until now, an all-around negative trend trading session today.

Catalyst Pharmaceuticals’s last close was $4.28, 31.39% below its 52-week high of $5.19.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 0.8% for the current quarter and 5.5% for the next. The company’s growth estimates for the present quarter is 12.5% and a drop 20% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.

Volatility

Catalyst Pharmaceuticals’s last day, last week, and last month’s average volatility was 1.40%, 1.72%, and 2.98%, respectively.

Catalyst Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 4.27%, 4.74%, and 5.66%, respectively.

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $3.95 at 14:13 EST, way below its 52-week high of $5.19 and way above its 52-week low of $2.55.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s value is above its 50-day moving average of $3.90 and way above its 200-day moving average of $3.49.

LEAVE A REPLY

Please enter your comment!
Please enter your name here